FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3159989178> ?p ?o ?g. }

• W3159989178 endingPage "1866" @default.
• W3159989178 startingPage "1857" @default.
• W3159989178 abstract "Background: Recent clinical trial results reported that stereotactic radiotherapy (SABR) may improve survival for patients with oligometastatic (OM) cancer. Given that these results come from a phase II trial, there remains considerable uncertainty about this finding, and about the cost-effectiveness of SABR for patients with OM cancer. In this analysis, we estimate the cost-effectiveness of SABR for oligometastatic cancer patients. Methods: A probabilistic time-dependent Markov model was constructed to simulate treatment of oligometastatic cancer patients over five- and ten-year time horizons. The primary data source was the phase II, Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastases (SABR-COMET )trial and supplemented with data from the literature. We estimated the effect of SABR and the standard of care (SoC) using quality-adjusted life-years (QALYs). Costs were measured from a provincial payer perspective (2018 Canadian dollars). Results: In the reference case analysis (five-year time horizon), SABR was associated with additional incremental costs of CAD 38,487 and an incremental QALY gain of 0.84. This resulted in an incremental cost-effectiveness ratio (ICER) of CAD 45,726 per QALY gained. Over a ten-year time horizon, the increased uncertainty in the long-term effectiveness of SABR resulted in an ICER of CAD 291,544 per QALY gained. Estimates from the probabilistic analysis indicated that at a willingness-to-pay (WTP) threshold of CAD 50,000 and CAD 100,000 per QALY gained, there is 54% and 78% probability (respectively) that SABR would be cost-effective using the five-year time horizon. Conclusions: The adoption of SABR therapy requires a considerable upfront capital investment. Our results suggest that the cost-effectiveness of SABR is contingent on the uncertainty in the evidence base. Further clinical trials to confirm the effectiveness of SABR and research into the real-world costs associated with this treatment could reduce the uncertainty around implementation of the technology." @default.
• W3159989178 created "2021-05-24" @default.
• W3159989178 creator A5037427247 @default.
• W3159989178 creator A5043733417 @default.
• W3159989178 creator A5066309274 @default.
• W3159989178 creator A5088319532 @default.
• W3159989178 date "2021-05-13" @default.
• W3159989178 modified "2023-09-25" @default.
• W3159989178 title "Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Tumors versus Standard of Care" @default.
• W3159989178 cites W1499636323 @default.
• W3159989178 cites W1902743617 @default.
• W3159989178 cites W1962912695 @default.
• W3159989178 cites W2011834196 @default.
• W3159989178 cites W2015107633 @default.
• W3159989178 cites W2033914729 @default.
• W3159989178 cites W2040042308 @default.
• W3159989178 cites W2077334961 @default.
• W3159989178 cites W2088277741 @default.
• W3159989178 cites W2105786384 @default.
• W3159989178 cites W2116338644 @default.
• W3159989178 cites W2128611498 @default.
• W3159989178 cites W2131110909 @default.
• W3159989178 cites W2282441333 @default.
• W3159989178 cites W2289992610 @default.
• W3159989178 cites W2302346359 @default.
• W3159989178 cites W2377410957 @default.
• W3159989178 cites W2401338497 @default.
• W3159989178 cites W2523470665 @default.
• W3159989178 cites W2549182546 @default.
• W3159989178 cites W2584663722 @default.
• W3159989178 cites W2767399829 @default.
• W3159989178 cites W2895716286 @default.
• W3159989178 cites W2901151612 @default.
• W3159989178 cites W2939770857 @default.
• W3159989178 cites W2972662142 @default.
• W3159989178 cites W2995444402 @default.
• W3159989178 cites W3032651552 @default.
• W3159989178 cites W4241696369 @default.
• W3159989178 doi "https://doi.org/10.3390/curroncol28030172" @default.
• W3159989178 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8161824" @default.
• W3159989178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34068400" @default.
• W3159989178 hasPublicationYear "2021" @default.
• W3159989178 type Work @default.
• W3159989178 sameAs 3159989178 @default.
• W3159989178 citedByCount "6" @default.
• W3159989178 countsByYear W31599891782021 @default.
• W3159989178 countsByYear W31599891782022 @default.
• W3159989178 crossrefType "journal-article" @default.
• W3159989178 hasAuthorship W3159989178A5037427247 @default.
• W3159989178 hasAuthorship W3159989178A5043733417 @default.
• W3159989178 hasAuthorship W3159989178A5066309274 @default.
• W3159989178 hasAuthorship W3159989178A5088319532 @default.
• W3159989178 hasBestOaLocation W31599891781 @default.
• W3159989178 hasConcept C112930515 @default.
• W3159989178 hasConcept C126322002 @default.
• W3159989178 hasConcept C149782125 @default.
• W3159989178 hasConcept C187625094 @default.
• W3159989178 hasConcept C19617505 @default.
• W3159989178 hasConcept C3019080777 @default.
• W3159989178 hasConcept C33923547 @default.
• W3159989178 hasConcept C509974204 @default.
• W3159989178 hasConcept C64332521 @default.
• W3159989178 hasConcept C71924100 @default.
• W3159989178 hasConcept C85393063 @default.
• W3159989178 hasConcept C91602232 @default.
• W3159989178 hasConceptScore W3159989178C112930515 @default.
• W3159989178 hasConceptScore W3159989178C126322002 @default.
• W3159989178 hasConceptScore W3159989178C149782125 @default.
• W3159989178 hasConceptScore W3159989178C187625094 @default.
• W3159989178 hasConceptScore W3159989178C19617505 @default.
• W3159989178 hasConceptScore W3159989178C3019080777 @default.
• W3159989178 hasConceptScore W3159989178C33923547 @default.
• W3159989178 hasConceptScore W3159989178C509974204 @default.
• W3159989178 hasConceptScore W3159989178C64332521 @default.
• W3159989178 hasConceptScore W3159989178C71924100 @default.
• W3159989178 hasConceptScore W3159989178C85393063 @default.
• W3159989178 hasConceptScore W3159989178C91602232 @default.
• W3159989178 hasIssue "3" @default.
• W3159989178 hasLocation W31599891781 @default.
• W3159989178 hasLocation W31599891782 @default.
• W3159989178 hasLocation W31599891783 @default.
• W3159989178 hasOpenAccess W3159989178 @default.
• W3159989178 hasPrimaryLocation W31599891781 @default.
• W3159989178 hasRelatedWork W1611416331 @default.
• W3159989178 hasRelatedWork W2031493814 @default.
• W3159989178 hasRelatedWork W2100535434 @default.
• W3159989178 hasRelatedWork W2120237881 @default.
• W3159989178 hasRelatedWork W2399655277 @default.
• W3159989178 hasRelatedWork W2509877404 @default.
• W3159989178 hasRelatedWork W2736209264 @default.
• W3159989178 hasRelatedWork W2810387901 @default.
• W3159989178 hasRelatedWork W3029169658 @default.
• W3159989178 hasRelatedWork W2777338963 @default.
• W3159989178 hasVolume "28" @default.
• W3159989178 isParatext "false" @default.
• W3159989178 isRetracted "false" @default.
• W3159989178 magId "3159989178" @default.
• W3159989178 workType "article" @default.